Conmed (CNMD) Other Operating Expenses (2010 - 2025)
Conmed posted quarterly Other Operating Expenses of $460.0 million for Q4 2025, up 339.8% year-on-year from $104.6 million in Q4 2024, and up 346.59% on a QoQ basis from $103.0 million in Q2 2025.
Conmed (CNMD) has 6 years of Other Operating Expenses data on file, last reported at $460.0 million in Q4 2025.
- For the quarter ending Q4 2025, Other Operating Expenses rose 339.8% year-over-year to $460.0 million; the trailing twelve-month figure through Mar 2026 stood at $563.0 million (up 79.21% YoY), and the FY2025 full-year result was $460.0 million, up 27.49% from the prior year.
- Other Operating Expenses for Q4 2025 stood at $460.0 million, up from $103.0 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $460.0 million in Q4 2025 and bottomed at $93.4 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 460.01 Mn |
| Jun 30, 2025 | 103.01 Mn |
| Mar 31, 2025 | 116.19 Mn |
| Dec 31, 2024 | 104.59 Mn |
| Jun 30, 2024 | 93.37 Mn |
| Dec 31, 2013 | -12.93 Mn |
| Sep 30, 2013 | 6.04 Mn |
| Jun 30, 2013 | 3.50 Mn |
| Mar 31, 2013 | 3.39 Mn |
| Dec 31, 2012 | 3.53 Mn |
| Sep 30, 2012 | 2.66 Mn |
| Jun 30, 2012 | 1.78 Mn |
| Mar 31, 2012 | 1.99 Mn |
| Dec 31, 2011 | 60.60 Mn |
| Jun 30, 2011 | 98,000.00 |
| Mar 31, 2011 | 694,000.00 |
| Dec 31, 2010 | 915,000.00 |
| Sep 30, 2010 | 291,000.00 |
| Jun 30, 2010 | 970,000.00 |